Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Heart (British Cardiac Society)|February 10, 2016
Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathyPatricia Reant, Mariana Mirabel, Guy Lloyd, et al.
The International Journal of Cardiovascular Imaging|December 12, 2025
The performance of free-breathing multiparametric SAturation-recovery single-SHot acquisition T1 and T2 mapping in cardiac allograft rejectionNikolaos Miaris, Husein Rajabali, Nicholas M Quaife, et al.
Open Heart|January 28, 2022
Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathyDaniel J Hammersley, Rachel J Buchan, Amrit S Lota, et al.
Frontiers in Cardiovascular Medicine|October 24, 2022
The addition of genetic testing and cardiovascular magnetic resonance to routine clinical data for stratification of etiology in dilated cardiomyopathyRavi J Amin, Deborah Morris-Rosendahl, Mat Edwards, et al.
European Journal of Heart Failure|September 6, 2022
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial DiseasesBettina Heidecker, Noa Dagan, Ran Balicer, et al.
Plos One|July 12, 2014
Dynamic conduction and repolarisation changes in early arrhythmogenic right ventricular cardiomyopathy versus benign outflow tract ectopy demonstrated by high density mapping & paced surface ECG analysisMalcolm C Finlay, Akbar K Ahmed, Alan Sugrue, et al.
Heart Rhythm|October 27, 2018
Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: Results from a multicenter studySaagar Mahida, Jeroen Venlet, Ardan Muammer Saguner, et al.
JAMA Network Open|June 29, 2019
Association of Titin-Truncating Genetic Variants With Life-threatening Cardiac Arrhythmias in Patients With Dilated Cardiomyopathy and Implanted DefibrillatorsBen Corden, Julian Jarman, Nicola Whiffin, et al.
JACC. Heart Failure|June 13, 2021
Heart Rate as a Marker of Relapse During Withdrawal of Therapy in Recovered Dilated CardiomyopathyBrian P Halliday, Ali Vazir, Ruth Owen, et al.
European Journal of Heart Failure|September 30, 2024
Long-term follow-up of the TRED-HF trial: Implications for therapy in patients with dilated cardiomyopathy and heart failure remissionLeanne Cheng, Daniel Hammersley, Aaraby Ragavan, et al.
Pageof 6